Home › Sickle Cell Disease › Wisconsin › Milwaukee
Sickle Cell Disease clinical trials in Milwaukee, WI
4 studies for Sickle Cell Disease are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
RecruitingPhase 3
- Versiti, CCBD_Milwaukee, Milwaukee
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Comprehensive Center for Bleeding Disorders, Milwaukee
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
RecruitingPhase 2
- Medical College of Wisconsin, Milwaukee
A Long-term Follow-up Study in Patients Who Received BEAM-101
RecruitingObservational study
- Medical College of Wisconsin, Milwaukee
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Atlanta, GA22 studies
- Washington, DC20 studies
- Memphis, TN18 studies
- Chicago, IL18 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- New York City, NY13 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Cincinnati, OH10 studies
- Houston, TX10 studies
- Boston, MA10 studies
Other studies in Milwaukee
- Breast Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)22 studies
- Lung Cancer21 studies
- Multiple Myeloma21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Pancreatic Cancer18 studies
- Non-Hodgkin Lymphoma18 studies
- Ovarian Cancer17 studies
- Acute Myeloid Leukemia17 studies
- Burkitt Lymphoma16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.